Montserrat Andrade Detrell
Director/Board Member at PHARMA MAR, S.A.
Net worth: 30 M $ as of 2024-03-30
Profile
Montserrat Andrade Detrell is currently a Director at Pharma Mar SA and a Member at Sociedad Española de Senología y Patología Mamaria.
In the past, she worked as the Head-Institutional Relations at Zeltia SA from 2007 to 2012.
Dr. Andrade Detrell has an undergraduate degree from Universidad Complutense de Madrid, a doctorate from the same university, a graduate degree from the University of Barcelona, another graduate degree from the University of Strasbourg, and a doctorate from University Carlos III of Madrid.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
PHARMA MAR SA
5.14% | 2023-06-12 | 954,460 ( 5.14% ) | 30 M $ | 2024-03-30 |
Montserrat Andrade Detrell active positions
| Companies | Position | Start |
|---|---|---|
| PHARMA MAR, S.A. | Director/Board Member | - |
| Sociedad Española de Senología y Patología Mamaria | Corporate Officer/Principal | - |
Former positions of Montserrat Andrade Detrell
| Companies | Position | End |
|---|---|---|
| ZELTIA SA | Corporate Officer/Principal | 2011-12-31 |
Training of Montserrat Andrade Detrell
| Universidad Complutense de Madrid | Undergraduate Degree |
| University of Barcelona | Graduate Degree |
| University of Strasbourg | Graduate Degree |
| University Carlos III of Madrid | Doctorate Degree |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| PHARMA MAR, S.A. | Health Technology |
| Private companies | 2 |
|---|---|
Zeltia SA
 Zeltia SA BiotechnologyHealth Technology Zeltia SA is a holding company, which develops marine-based drugs in the field of oncology. It operates through the Biopharmaceuticals and Consumer Chemicals segments. The Biopharmaceuticals segment engages in the research and marketing of anti-tumor drugs, diagnosis kits, and development of therapies based on reducing or silencing gene expression. The Consumer Chemicals segment produces and markets insecticides and air fresheners for household use, household products, wood treatment and decoration products, paints, and related products. The company was founded on August 3, 1939 and is headquartered in Madrid, Spain. | Health Technology |
| Sociedad Española de Senología y Patología Mamaria |
- Stock Market
- Insiders
- Montserrat Andrade Detrell
